First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong; T. Asakura; M. Ishii; S. Yoda; K. Masaki; T. Sakagami; E. Iwasaki; Y. Yamagishi; T. Kanai; T. Betsuyaku; N. Hasegawa

doi:10.1016/j.nmni.2018.10.001

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong
, T. Asakura
, M. Ishii
, S. Yoda
, K. Masaki
, T. Sakagami
, E. Iwasaki
, Y. Yamagishi
, T. Kanai
, T. Betsuyaku
, N. Hasegawa

研究成果: Article › 査読

8 被引用数 (Scopus)

抄録

This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

本文言語	English
ページ（範囲）	4-6
ページ数	3
ジャーナル	New Microbes and New Infections
巻	27
DOI	https://doi.org/10.1016/j.nmni.2018.10.001
出版ステータス	Published - 2019 1月

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

微生物学
感染症

文献へのアクセス

10.1016/j.nmni.2018.10.001

他のファイルとリンク

フィンガープリント

「First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Namkoong, H., Asakura, T., Ishii, M., Yoda, S., Masaki, K., Sakagami, T., Iwasaki, E., Yamagishi, Y., Kanai, T., Betsuyaku, T., & Hasegawa, N. (2019). First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies. New Microbes and New Infections, 27, 4-6. https://doi.org/10.1016/j.nmni.2018.10.001

Namkoong, H, Asakura, T, Ishii, M, Yoda, S, Masaki, K, Sakagami, T, Iwasaki, E, Yamagishi, Y, Kanai, T, Betsuyaku, T & Hasegawa, N 2019, 'First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies', New Microbes and New Infections, vol. 27, pp. 4-6. https://doi.org/10.1016/j.nmni.2018.10.001

@article{81b814b214e4452b98685d6c3c494790,

title = "First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies",

abstract = "This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.",

keywords = "Anti–interferon gamma (IFN-γ) autoantibody, Mycobacterium aviumcomplex (MAC), disseminated Mycobacterium aviumcomplex infection, hepatobiliary infection, jaundice",

author = "H. Namkoong and T. Asakura and M. Ishii and S. Yoda and K. Masaki and T. Sakagami and E. Iwasaki and Y. Yamagishi and T. Kanai and T. Betsuyaku and N. Hasegawa",

note = "Publisher Copyright: {\textcopyright} 2018 The Author(s)",

year = "2019",

month = jan,

doi = "10.1016/j.nmni.2018.10.001",

language = "English",

volume = "27",

pages = "4--6",

journal = "New Microbes and New Infections",

issn = "2052-2975",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

AU - Namkoong, H.

AU - Asakura, T.

AU - Ishii, M.

AU - Yoda, S.

AU - Masaki, K.

AU - Sakagami, T.

AU - Iwasaki, E.

AU - Yamagishi, Y.

AU - Kanai, T.

AU - Betsuyaku, T.

AU - Hasegawa, N.

PY - 2019/1

Y1 - 2019/1

N2 - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

AB - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

KW - Anti–interferon gamma (IFN-γ) autoantibody

KW - Mycobacterium aviumcomplex (MAC)

KW - disseminated Mycobacterium aviumcomplex infection

KW - hepatobiliary infection

KW - jaundice

UR - https://www.scopus.com/pages/publications/85056726089

UR - https://www.scopus.com/pages/publications/85056726089#tab=citedBy

U2 - 10.1016/j.nmni.2018.10.001

DO - 10.1016/j.nmni.2018.10.001

M3 - Article

AN - SCOPUS:85056726089

SN - 2052-2975

VL - 27

SP - 4

EP - 6

JO - New Microbes and New Infections

JF - New Microbes and New Infections

ER -